Jeff Castelli
57Patents
22h-index
6Co-inventors
77Inventor score
Filing activity: May 16, 2007 → May 31, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7851143B2 | Assays for diagnosing and evaluating treatment options for Fabry disease | Physics | 54 | Active |
| US9000011B2 | Methods for treatment of Fabry disease | Physics | 50 | Active |
| US10471053B2 | Methods of treating Fabry patients having renal impairment | Human Necessities | 48 | Active |
| US10251873B2 | Methods of treating fabry patients having renal impairment | Human Necessities | 48 | Active |
| US10406143B2 | Methods for treatment of fabry disease | Physics | 48 | Active |
| US10525045B2 | Dosing regimens for the treatment of lysosomal storage diseases using pharmacological chaperones | Human Necessities | 48 | Active |
| US9999618B2 | Dosing regimens for the treatment of lysosomal storage diseases using pharmacological chaperones | Human Necessities | 48 | Active |
| US10383864B2 | Methods for treatment of Fabry disease | Physics | 48 | Active |
| US9480682B2 | Methods for treatment of Fabry disease | Physics | 48 | Active |
| US9987263B2 | Methods for treatment of Fabry disease | Physics | 48 | Active |
| US10874657B2 | Methods of treating Fabry patients having renal impairment | Human Necessities | 37 | Active |
| US10874655B2 | Methods of treating fabry patients having renal impairment | Human Necessities | 37 | Active |
| US10857142B2 | Methods of treating Fabry patients having renal impairment | Human Necessities | 37 | Active |
| US10799491B2 | Methods of treating Fabry patients having renal impairment | Human Necessities | 37 | Active |
| US10925866B2 | Dosing regimens for the treatment of lysosomal storage diseases using pharmacological chaperones | Human Necessities | 37 | Active |
| US10806727B2 | Methods of treating fabry patients having renal impairment | Human Necessities | 37 | Active |
| US10849890B2 | Methods of treating Fabry patients having renal impairment | Human Necessities | 37 | Active |
| US10857141B2 | Methods of treating Fabry patients having renal impairment | Human Necessities | 37 | Active |
| US10792279B2 | Methods of treating Fabry patients having renal impairment | Human Necessities | 37 | Active |
| US10849889B2 | Methods of treating Fabry patients having renal impairment | Human Necessities | 37 | Active |
| US10874656B2 | Methods of treating Fabry patients having renal impairment | Human Necessities | 37 | Active |
| US10792278B2 | Methods of treating Fabry patients having renal impairment | Human Necessities | 37 | Active |
| US11304940B2 | Methods of treating Fabry patients having renal impairment | Human Necessities | 8 | Active |
| US11426396B2 | Methods of treating Fabry patients having renal impairment | Human Necessities | 7 | Active |
| US11357765B1 | Methods of treating Fabry patients having renal impairment | Human Necessities | 6 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.